ISRCTN52829313已完成不适用
eonatal immunisation with pneumoccal conjugate vaccines: immunogenicity and the generation memory (Kenya)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy infants born to mothers tested human immunodeficiency virus (HIV) negative in the voluntary counselling and testing service
- •2. Not known to have congenital immune deficiency
- •3. Birth weight greater than 2500 g
- •4. Informed consent
排除标准
- •1. Infants requiring ongoing hospitalisation after birth
- •2. Suspected immune deficiency
- •3. Participation in another clinical trial
- •Any child who suffers a serious adverse event directly attributable to pneumococcal vaccination will be excluded from continued participation.
研究者
相似试验
尚未招募
不适用
Efficacy of pneumococcal conjugate vaccine in preventing acquisition and carriage of pneumococcal vaccine serotypes in Tanzanian children with human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS)Pneumococcal diseaseHIV/AIDSPublic Health - EpidemiologyInfection - Studies of infection and infectious agentsACTRN12610000999033Prof Robert Booy216
已完成
不适用
Evaluation of pneumococcal conjugate vaccine (Prevenar) in patients with myeloma and chronic lymphocytic leukaemiaCancerISRCTN21541376Central Manchester and Manchester Children's Hospital (UK)97
进行中（未招募）
1 期
Evaluation of pneumococcal conjugate vaccine (Prevenar) in patients with myeloma and chronic lymphocytic leukaemia - Pneumococcal conjugate vaccination in Haematology patients: Version 1Pneumococcal disease is a common form of meningitis, septicaemia and pneumonia. Those individuals at highest risk include children, the elderly and persons whose immune systems are impaired. This latter group is diverse includes patients with the haematological disorders myeloma and chronic lymphocytic leukaemia in whom infections are a leading cause of death.EUCTR2005-003761-16-GBDepartment of R & D, Central Manchester and Manchester Children's Hospital NHS Trust97
进行中（未招募）
不适用
Revaccination with Pneumococcal Conjugate Vaccine - Characterization of the Immune Response after Polysaccharide (REPLAY) - REPLAYInvasive pneumococcal diseaseMedDRA version: 9.1Level: LLTClassification code 10061353Term: Pneumococcal infectionEUCTR2008-006194-33-ISWyeth Research Division of Wyeth Pharmaceuticals Inc.224
进行中（未招募）
1 期
Immunogenicity of conjugate pneumococcal vaccine (Prevenar) in patients with ataxia -telangiectasia (AT) including a randomised study of one versus two doses of vaccine. - Immunogenicity of Prevenar in Ataxia telangiectasiaEUCTR2005-004122-70-GBGreat Ormond Street Hospital30